Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report - Takeaways - MDSpire

Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report

  • By

  • Wendy A. Brown

  • Ronald Liem

  • Salman Al-Sabah

  • Mehran Anvari

  • Camilo Boza

  • Ricardo V. Cohen

  • Amir Ghaferi

  • Villy Våge

  • Jacques Himpens

  • Lilian Kow

  • John Morton

  • Mario Musella

  • Francois Pattou

  • Nasser Sakran

  • Benjamin Clapp

  • Gerhard Prager

  • Scott Shikora

  • April 9, 2024

  • 0 min

Share

  • 1

    Metabolic bariatric surgery (MBS) effectively treats obesity and related diseases, but real-world outcomes are less understood.

  • 2

    The IFSO Global Registry collects uniform data on MBS to improve understanding of patient demographics, procedures, and safety.

  • 3

    The eighth IFSO report included aggregated data from 24 countries and 2 regional registries, covering 502,150 MBS procedures.

  • 4

    Most reported procedures were primary MBS (89.6%), with revisional procedures accounting for 10.4% of the total.

  • 5

    Countries like Sweden and Michigan reported high case ascertainment rates, ensuring comprehensive data collection for MBS.

Original Source(s)

Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report

  • by Wendy A. Brown, Ronald Liem, Salman Al-Sabah, Mehran Anvari, Camilo Boza, Ricardo V. Cohen, Amir Ghaferi, Villy Våge, Jacques Himpens, Lilian Kow, John Morton, Mario Musella, Francois Pattou, Nasser Sakran, Benjamin Clapp, Gerhard Prager, Scott Shikora

  • April 9, 2024

Related Content

The Role of Total Small Bowel Length and its Measurement in Metabolic Bariatric Surgery. A Systematic Review

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation